Literature DB >> 30173315

Mapping the Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory to the Health Utility Index Mark III.

Yin Bun Cheung1,2, Hui Xing Tan3, Vivian Wei Wang4, Nagaendran Kandiah5, Nan Luo3, Gerald C H Koh3, Hwee Lin Wee3,6.   

Abstract

PURPOSE: To map the Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL) to the Health Utility Index Mark III (HUI3) in people living with dementia (PWD) and to compare the performance of five methods for mapping.
METHODS: A cross-sectional study of 346 dyads of community-dwelling PWD and family caregiver was carried out in Singapore. ADCS-ADL and HUI3 were rated by the family caregivers. Disease severity ratings and Mini Mental State Examination (MMSE) results were retrieved from medical records. A recently proposed mapping method called the Mean Rank Method (MRM) was described and applied, and the results were compared with regression-based mapping, including ordinary least squares, censored least absolute deviation (CLAD), Tobit and response mapping.
RESULTS: The MRM produced a mapped utility distribution that closely resembled the observed utility distribution. The standard deviations (SDs) of the observed and MRM-mapped utility were both 0.340, whereas the SDs of the other mapped utilities ranged from 0.243 (response mapping) to 0.283 (CLAD). Regressing the MRM- and CLAD-mapped and observed utility values upon disease severity and MMSE gave similar regression lines (each P > 0.05). Regressing the other mapped utility values upon the covariates under- (over-) estimated the utility of good (poor) clinical states. However, regression-based mapping methods gave a better fit at the individual level, as measured by root mean square error, mean absolute error and R2. K fold cross-validation gave similar results.
CONCLUSIONS: The MRM is accurate at the group level. The regression-based mapping methods are more accurate for making individual-level prediction. In addition, CLAD also performed reasonably well at the group level.

Entities:  

Keywords:  Activities of daily living; Dementia; Health Utility Index Mark III; Health utility; Mapping

Mesh:

Year:  2018        PMID: 30173315     DOI: 10.1007/s11136-018-1991-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  31 in total

Review 1.  Health outcomes in economic evaluation: the QALY and utilities.

Authors:  Sarah J Whitehead; Shehzad Ali
Journal:  Br Med Bull       Date:  2010-10-29       Impact factor: 4.291

Review 2.  A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures.

Authors:  John E Brazier; Yaling Yang; Aki Tsuchiya; Donna Louise Rowen
Journal:  Eur J Health Econ       Date:  2009-07-08

3.  An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  D Galasko; D Bennett; M Sano; C Ernesto; R Thomas; M Grundman; S Ferris
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

4.  Mapping to obtain EQ-5D utility values for use in NICE health technology assessments.

Authors:  Louise Longworth; Donna Rowen
Journal:  Value Health       Date:  2013 Jan-Feb       Impact factor: 5.725

5.  Should linking replace regression when mapping from profile-based measures to preference-based measures?

Authors:  Peter M Fayers; Ron D Hays
Journal:  Value Health       Date:  2014-03       Impact factor: 5.725

Review 6.  Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.

Authors:  Louise Longworth; Yaling Yang; Tracey Young; Brendan Mulhern; Mónica Hernández Alava; Clara Mukuria; Donna Rowen; Jonathan Tosh; Aki Tsuchiya; Pippa Evans; Anju Devianee Keetharuth; John Brazier
Journal:  Health Technol Assess       Date:  2014-02       Impact factor: 4.014

7.  Prediction of burden in family caregivers of patients with dementia: a perspective of optimism based on generalized expectancies of control.

Authors:  Israel Contador; Bernardino Fernández-Calvo; David L Palenzuela; Soraia Miguéis; Francisco Ramos
Journal:  Aging Ment Health       Date:  2012       Impact factor: 3.658

8.  Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease.

Authors:  I-Chan Huang; Constantine Frangakis; Mark J Atkinson; Richard J Willke; Walter L Leite; W Bruce Vogel; Albert W Wu
Journal:  Health Serv Res       Date:  2008-02       Impact factor: 3.402

9.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

10.  Mapping the functional assessment of cancer therapy-breast (FACT-B) to the 5-level EuroQoL Group's 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic Asian population.

Authors:  Yin Bun Cheung; Nan Luo; Raymond Ng; Chun Fan Lee
Journal:  Health Qual Life Outcomes       Date:  2014-12-12       Impact factor: 3.186

View more
  3 in total

1.  Mapping the Shah-modified Barthel Index to the Health Utility Index Mark III by the Mean Rank Method.

Authors:  Yin Bun Cheung; Hui Xing Tan; Nan Luo; Hwee Lin Wee; Gerald C H Koh
Journal:  Qual Life Res       Date:  2019-07-27       Impact factor: 4.147

Review 2.  The Humanistic and Economic Burden of Alzheimer's Disease.

Authors:  Amir Abbas Tahami Monfared; Michael J Byrnes; Leigh Ann White; Quanwu Zhang
Journal:  Neurol Ther       Date:  2022-02-22

3.  Mapping the medical outcomes study HIV health survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3 L) utility index.

Authors:  Yuan Shi; Jennifer Thompson; A Sarah Walker; Nicholas I Paton; Yin Bun Cheung
Journal:  Health Qual Life Outcomes       Date:  2019-05-10       Impact factor: 3.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.